A Single Synonymous Variant (c.354G>A [p.P118P]) in Confers Enhanced Specific Activity
Name:
ijms-20-05734-v2 (1).pdf
Size:
1.825Mb
Format:
PDF
Description:
Final Published Version
Author
Hunt, RyanHettiarachchi, Gaya
Katneni, Upendra
Hernandez, Nancy
Holcomb, David
Kames, Jacob
Alnifaidy, Redab
Lin, Brian
Hamasaki-Katagiri, Nobuko
Wesley, Aaron
Kafri, Tal
Morris, Christina
Bouché, Laura
Panico, Maria
Schiller, Tal
Ibla, Juan
Bar, Haim
Ismail, Amra
Morris, Howard
Komar, Anton
Kimchi-Sarfaty, Chava
Affiliation
Univ Arizona, Dept Emergency Med, Banner Univ Med CtrIssue Date
2019-11-15Keywords
ADAMTS13codon usage
post-translational modifications
ribosome profiling
specific activity
synonymous variant
translation
Metadata
Show full item recordPublisher
MDPICitation
Hunt, R.; Hettiarachchi, G.; Katneni, U.; Hernandez, N.; Holcomb, D.; Kames, J.; Alnifaidy, R.; Lin, B.; Hamasaki-Katagiri, N.; Wesley, A.; Kafri, T.; Morris, C.; Bouché, L.; Panico, M.; Schiller, T.; Ibla, J.; Bar, H.; Ismail, A.; Morris, H.; Komar, A.; Kimchi-Sarfaty, C. A Single Synonymous Variant (c.354G>A [p.P118P]) in ADAMTS13 Confers Enhanced Specific Activity. Int. J. Mol. Sci. 2019, 20, 5734.Rights
Copyright © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Synonymous variants within coding regions may influence protein expression and function. We have previously reported increased protein expression levels ex vivo (~120% in comparison to wild-type) from a synonymous polymorphism variant, c.354G>A [p.P118P], of the ADAMTS13 gene, encoding a plasma protease responsible for von Willebrand Factor (VWF) degradation. In the current study, we investigated the potential mechanism(s) behind the increased protein expression levels from this variant and its effect on ADAMTS13 physico-chemical properties. Cell-free assays showed enhanced translation of the c.354G>A variant and the analysis of codon usage characteristics suggested that introduction of the frequently used codon/codon pair(s) may have been potentially responsible for this effect. Limited proteolysis, however, showed no substantial influence of altered translation on protein conformation. Analysis of post-translational modifications also showed no notable differences but identified three previously unreported glycosylation markers. Despite these similarities, p.P118P variant unexpectedly showed higher specific activity. Structural analysis using modeled interactions indicated that subtle conformational changes arising from altered translation kinetics could affect interactions between an exosite of ADAMTS13 and VWF resulting in altered specific activity. This report highlights how a single synonymous nucleotide variation can impact cellular expression and specific activity in the absence of measurable impact on protein structure.Note
Open access journalISSN
1422-0067PubMed ID
31731663Version
Final published versionSponsors
Hemostasis Branch/Division of Plasma Protein Therapeutics/Office of Tissues and Advanced Therapies/Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration; FDA's MODSCI grant; American Heart AssociationAmerican Heart Association [13GRNT17070025]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R15HL121779-01A1]ae974a485f413a2113503eed53cd6c53
10.3390/ijms20225734
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).